Stage IV Triple-Negative Breast Cancer: Deltra's Patient Story
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Biomarkers
- ER-negative; PR-negative; HER2-negative (triple-negative)
- Sex
- Female
- Outcome
- Living With Cancer
Treatment course, step by step
- Ongoing metastatic breast cancer care; quality-of-life discussion centered on body image, confidence, and intimacy after diagnosis.
What happened, in summary
Deltra James was diagnosed at 33 with de novo Stage IV triple-negative metastatic breast cancer. In this conversation with Melissa Berry, she focused on the emotional and body-image side of living after a breast cancer diagnosis. Cancer can leave visible and invisible changes: scars, hair loss, shifts in sexuality, altered confidence, and the fear of being seen differently. Deltra's advocacy makes room for those realities without reducing a person to them. She speaks to the process of learning to love a changed body, rebuilding self-esteem, and finding ways to feel desirable and whole while living with metastatic disease. The discussion also emphasizes that confidence is not instant. It can grow through honesty, community, supportive relationships, and practical steps that help a person reconnect with themselves before intimacy with someone else. For someone living with advanced cancer, that work can happen alongside scans, treatment decisions, parenting, and advocacy. As of September 2024, Deltra was living with metastatic breast cancer and using her voice to help others reclaim confidence, self-worth, and connection after diagnosis. Her message gives other patients permission to grieve changes while still seeking joy, desire, style, and a sense of ownership over their bodies.
Where this story comes from
This is a lay summary of an account first published by Dear Cancer, I'm Beautiful (LBBC). Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer